CLINICAL_TRIALS
trial_result
· 2015-05-21
Clinical Trial Update: A Two-Part, 12-Week Study of Etoricoxib as a Treatment for Rheumatoid Arthritis (RA) (MK-0663-107) [Phase 3]
Summary
Phase 3, two-part, 12-week trial of etoricoxib for rheumatoid arthritis has completed and results were posted on 2015-05-21.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Organon and Co | Conditions: Arthritis, Rheumatoid | Phase 3 | Status: COMPLETED | Results posted: 2015-05-21